Health Ministers Discuss Cooperation At BRIC Talks

BMI View: Recent meetings between Brazil, Russia, India and China (BRIC) have aimed to establish the bloc as the drug producer of choice for developing countries looking for cheap, effective and accessible medicines. If successful, the group's ambitions will represent a considerable threat to the way European and North American pharmaceutical companies establish drug prices across these emerging markets. BMI believes a pricing index, which highlights regional disparities, will push drugmakers to establish more consistent global

To read the full article, please choose one of the following options: